Extragenital/extraungueal Bowen disease arising in the absence of field cancerisation is not associated with human papillomavirus infection: Results from a pilot study

2020 ◽  
Vol 61 (4) ◽  
Author(s):  
Claudio Conforti ◽  
Caterina Dianzani ◽  
Serena Bonin ◽  
Ermanno Nardon ◽  
Roberta Giuffrida ◽  
...  
2016 ◽  
Vol 38 (10) ◽  
pp. 751-757 ◽  
Author(s):  
Marián Švajdler ◽  
Roman Mezencev ◽  
Jana Kašpírková ◽  
Denisa Kacerovská ◽  
Dmitry V. Kazakov ◽  
...  

2011 ◽  
Vol 122 (2) ◽  
pp. 303-306 ◽  
Author(s):  
Jin Hwi Kim ◽  
Seog Nyeon Bae ◽  
Chung Won Lee ◽  
Min Jong Song ◽  
Sung Jong Lee ◽  
...  

2000 ◽  
Vol 34 (6) ◽  
pp. 194-200 ◽  
Author(s):  
Joakim Dillner ◽  
Chris J. L. M. Meijer ◽  
Geo von Krogh ◽  
Simon Horenblas

2017 ◽  
pp. 34-36
Author(s):  
N.A. Shcherbina ◽  
◽  
D.I. Demidenko ◽  
A.D. Demidenko ◽  
N.V. Kapustnik ◽  
...  

Under our supervision there were 66 women with a diagnosis of "dysplasia of cervical epithelium mild" on the background of persistent human papillomavirus infection (PVI). With the aim of improving the treatment of dysplasia of the 1st degree in rehabilitation activities after cryoablation there were applied drugs Distreptaza and inducer of interferon. The results of treatment were evaluated after 3 months. For patients of the 1st group (18 women) who underwent only cryoablation, the efficacy of therapy was 77.8%. In the 2nd group (22 women) after cryoablation was used inducer of interferon, the effectiveness made up of 90.9%. The maximum effect of treatment - 100% recorded in 3rd group (26 patients), where after cryoablation was carried out treatment with Distreptaza and inducer of interferon. The results of treatment obtained in this group allow to recommend the complex therapy of PVI in conditions of female consultation. Key words: dysplasia, HPV, cryosurgery, Distreptaza, inducer of interferon.


Sign in / Sign up

Export Citation Format

Share Document